Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 38 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
371 19.7 months Metastatic breast cancer and locally advanced breast cancer 4 Chemotherapy
Herlev Hospital Denmark 12/2011
Treatment Details: Patients: This phase III study involved women with locally advanced or metastatic breast cancer who were divided into two separate treatment groups. Group A consisted of 170 patients with
 
372 19.7 months Metastatic colorectal carcinoma 5 Biologic therapy
Chemotherapy
Instituto do Câncer do Estado de São Paulo Brazil 10/2012
Treatment Details: Patients: This study involved previously untreated metastatic colorectal carcinoma patients who were divided into two separate treatment groups. Group A consisted of 502 patients with a me
 
373 19.7 months HER2-positive metastatic breast cancer 4 Biologic therapy
Jules Bordet Institute Belgium 12/2013
Treatment Details: Patients: This phase 2 study involved female, previously treated, HER2+, locally advanced/metastatic breast cancer patients who were divided into two separate treatment groups. Group A ha
 
374 19.7 months Metastatic colorectal cancer 4 Chemotherapy
Centre René Gauducheau France 4/2014
Treatment Details: Patients: This phase 3 study involved metastatic colorectal cancer patients who were separated into four different groups based on treatment and their genetic status of the KRAS gene. Grou
 
375 19.6 months Malignant pleural mesothelioma 4 Chemotherapy
JuntendoUniversitySchoolofMedicine Japan 3/2014
Treatment Details: Patients: This study involved malignant pleural mesothelioma patients who were divided into two separate treatment groups. Group A consisted of 17 patients with a median age of 66 years; 9
 
376 19.6 months Malignant pleural mesothelioma 4 Chemotherapy
Instituto Nacional de Cancerologia Mexico 2/2012
Treatment Details: Patients: This phase II study involved 38 advanced malignant pleural mesothelioma patients who had not received prior chemotherapy. The median patient age was 60.1 years and 76.6% were mal
 
377 19.6 months Metastatic renal cell carcinoma Biologic therapy
Dana-Farber Cancer Institute United States 1/2008
Treatment Details: Patients: This study involved 53 patients with renal cell carcinoma. Most of the patients (41) had papillary tumors, and the rest had chromophobe tumors. The median age was 59, ranging fr
 
378 19.6 months GBM 4 Biologic therapy
Chemotherapy
Radiation
University of California, Los Angeles United States 1/2011
Treatment Details: Patients: This study involved 70 patients with newly diagnosed glioblastoma multiforme with no prior treatment. Patients had a median age of 57.4 years and 56% were male. Treatment: Pa
 
379 19.6 months Advanced colorectal cancer 4 Chemotherapy
Kurume University School of Medicine Japan 1/2011
Treatment Details: Patients: This study involved 48 advanced or metastatic colorectal cancer patients with a median age of 61.5 years. 48% of the patients were male. Treatment: Patients were treated with
 
380 19.6 months GBM 4 Biologic therapy
Chemotherapy
Radiation
Reed Neurological Research Center United States 1/2011
Treatment Details: Patients: This study involved 70 patients with newly diagnosed glioblastoma multiforme. The median age was 57.4 years and 56% of patients were male. Treatment: Patients were treated wi
 
Page 38 of 187  | Previous Page  | Next Page